Cargando…
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
Cancer-related anorexia and cachexia syndrome (CACS) is a complex multifactorial condition, with loss of lean body mass, chronic inflammation, severe metabolic derangements, reduced food intake, reduced physical activity, and poor quality of life as key symptoms. Cachexia recognizes different phases...
Autores principales: | Mantovani, Giovanni, Madeddu, Clelia, Macciò, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746778/ https://www.ncbi.nlm.nih.gov/pubmed/23976842 http://dx.doi.org/10.2147/DDDT.S39771 |
Ejemplares similares
-
Cancer cachexia and chronic inflammation: an unbreakable bond
por: Macciò, Antonio, et al.
Publicado: (2023) -
Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease
por: Maccio, Antonio, et al.
Publicado: (2021) -
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome [Retraction]
Publicado: (2013) -
Experimental Drugs for Chemotherapy- and Cancer-Related Anemia
por: Madeddu, Clelia, et al.
Publicado: (2021) -
Pathophysiology of anorexia in the cancer cachexia syndrome
por: Ezeoke, Chukwuemeka Charles, et al.
Publicado: (2015)